1. Blencowe H, Cousens S, Oestergaard MZ, Chou D, Moller AB, Narwal R, et al. National, regional, and worldwide estimates of preterm birth rates in the year 2010 with time trends since 1990 for selected countries: a systematic analysis and implications. Lancet 2012;379:2162–72.
2. Woythaler M. Neurodevelopmental outcomes of the late preterm infant. Semin Fetal Neonatal Med 2019;24:54–9.
3. Raju TN, Higgins RD, Stark AR, Leveno KJ. Optimizing care and outcome for late-preterm (near-term) infants: a summary of the workshop sponsored by the National Institute of Child Health and Human Development. Pediatrics 2006;118:1207–14.
4. Kugelman A, Colin AA. Late preterm infants: near term but still in a critical developmental time period. Pediatrics 2013;132:741–51.
5. McGowan JE, Alderdice FA, Holmes VA, Johnston L. Early childhood development of late-preterm infants: a systematic review. Pediatrics 2011;127:1111–24.
6. Heinonen K, Eriksson JG, Lahti J, Kajantie E, Pesonen AK, Tuovinen S, et al. Late preterm birth and neurocognitive performance in late adulthood: a birth cohort study. Pediatrics 2015;135:e818–25.
8. Celik IH, Demirel G, Canpolat FE, Dilmen U. A common problem for neonatal intensive care units: late preterm infants, a prospective study with term controls in a large perinatal center. J Matern Fetal Neonatal Med 2013;26:459–62.
10. Cuestas E, Gaido MI, Capra RH. Transient neonatal hyperthyrotropinemia is a risk factor for developing persistent hyperthyrotropinemia in childhood with repercussion on developmental status. Eur J Endocrinol 2015;172:483–90.
11. Oppenheimer JH, Schwartz HL. Molecular basis of thyroid hormone-dependent brain development. Endocr Rev 1997;18:462–75.
12. Grosse SD, Van Vliet G. Prevention of intellectual disability through screening for congenital hypothyroidism: how much and at what level? Arch Dis Child 2011;96:374–9.
13. Van Wassenaer AG, Kok JH. Hypothyroxinaemia and thyroid function after preterm birth. Semin Neonatol 2004;9:3–11.
14. American Academy of Pediatrics; Rose SR, Section on Endocrinology and Committee on Genetics; American Thyroid Association; Brown RS, Public Health Committee; Lawson Wilkins Pediatric Endocrine Society; Foley T, et al. Update of newborn screening and therapy for congenital hypothyroidism. Pediatrics 2006;117:2290–303.
16. Kucharska AM, Ben-Skowronek I, Walczak M, Oltarzewski M, Szalecki M, Jackowska T, et al. Congenital hypothyroidism: Polish recommendations for therapy, treatment monitoring, and screening tests in special categories of neonates with increased risk of hypothyroidism. Endokrynol Pol 2016;67:536–47.
17. Leger J, Olivieri A, Donaldson M, Torresani T, Krude H, van Vliet G, et al. European Society for Paediatric Endocrinology consensus guidelines on screening, diagnosis, and management of congenital hypothyroidism. Horm Res Paediatr 2014;81:80–103.
18. Zung A, Yehieli A, Blau A, Almashanu S. Characteristics of delayed thyroid stimulating hormone elevation in neonatal intensive care unit newborns. J Pediatr 2016;178:135–40.
20. Papile LA, Burstein J, Burstein R, Koffler H. Incidence and evolution of subependymal and intraventricular hemorrhage: a study of infants with birth weights less than 1,500 gm. J Pediatr 1978;92:529–34.
21. Kinsella JP, Greenough A, Abman SH. Bronchopulmonary dysplasia. Lancet 2006;367:1421–31.
22. Larson C, Hermos R, Delaney A, Daley D, Mitchell M. Risk factors associated with delayed thyrotropin elevations in congenital hypothyroidism. J Pediatr 2003;143:587–91.
23. Woo HC, Lizarda A, Tucker R, Mitchell ML, Vohr B, Oh W, et al. Congenital hypothyroidism with a delayed thyroid-stimulating hormone elevation in very premature infants: incidence and growth and developmental outcomes. J Pediatr 2011;158:538–42.
24. Sun X, Lemyre B, Nan X, Harrold J, Perkins SL, Lawrence SE, et al. Free thyroxine and thyroid-stimulating hormone reference intervals in very low birth weight infants at 3-6 weeks of life with the Beckman Coulter Unicel DxI 800. Clin Biochem 2014;47:16–8.
27. Linder N, Davidovitch N, Reichman B, Kuint J, Lubin D, Meyerovitch J, et al. Topical iodine-containing antiseptics and subclinical hypothyroidism in preterm infants. J Pediatr 1997;131:434–9.
28. Aitken J, Williams FL. A systematic review of thyroid dysfunction in preterm neonates exposed to topical iodine. Arch Dis Child Fetal Neonatal Ed 2014;99:F21–8.
29. Ares S, Quero J, de Escobar GM. Iodine balance, iatrogenic excess, and thyroid dysfunction in premature newborns. Semin Perinatol 2008;32:407–12.
31. Bagnoli F, Farmeschi L, Peruzzi L, Musaraf A, Paffetti P, Badii S, et al. Altered thyroid function in small for gestational age newborns: study based on screening test for congenital hypothyroidism. J Pediatr Sci 2010;4:e55.
32. Franco B, Laura F, Sara N, Salvatore G. Thyroid function in small for gestational age newborns: a review. J Clin Res Pediatr Endocrinol 2013;5 Suppl 1:2–7.
33. Uchiyama A, Watanabe H, Nakanishi H, Totsu S. Small for gestational age is a risk factor for the development of delayed thyrotropin elevation in infants weighing less than 2000 g. Clin Endocrinol (Oxf) 2018;89:431–6.
35. Vigone MC, Caiulo S, Di Frenna M, Ghirardello S, Corbetta C, Mosca F, et al. Evolution of thyroid function in preterm infants detected by screening for congenital hypothyroidism. J Pediatr 2014;164:1296–302.
36. Bijarnia S, Wilcken B, Wiley VC. Newborn screening for congenital hypothyroidism in very-low-birth-weight babies: the need for a second test. J Inherit Metab Dis 2011;34:827–33.
37. Hashemipour M, Hovsepian S, Ansari A, Keikha M, Khalighinejad P, Niknam N. Screening of congenital hypothyroidism in preterm, low birth weight and very low birth weight neonates: a systematic review. Pediatr Neonatol 2018;59:3–14.
38. Chung ML, Yoo HW, Kim KS, Lee BS, Pi SY, Lim G, et al. Thyroid dysfunctions of prematurity and their impacts on neurodevelopmental outcome. J Pediatr Endocrinol Metab 2013;26:449–55.
39. Lim G, Lee YK, Han HS. Early discontinuation of thyroxine therapy is possible in most very low-birthweight infants with hypothyroidism detected by screening. Acta Paediatr 2014;103:e123. –9.
40. Jung JM, Jin HY, Chung ML. Feasibility of an early discontinuation of thyroid hormone treatment in very-low-birth-weight infants at risk for transient or permanent congenital hypothyroidism. Horm Res Paediatr 2016;85:131–9.